Oxford Nanopore Technologies (LON:ONT) Chief Financial Officer Nick Keher outlined the company’s progress in expanding beyond its historically research-led revenue base, highlighting rapid growth in clinical and applied industrial end markets, continued investment in regulated diagnostics pathways, and management’s updated expectations for growth and profitability. Revenue mix and growth across end markets Keher said research […]